← Search

Excel · study · 2026

Antibody-opsonized extracellular traps reprogram macrophage responses and suppress their T cell-directed pro-inflammatory activity

Listed in NCBI GEO

Macrophages and neutrophils coordinate inflammatory and reparative immunity, and dysregulated interactions between these cells contribute to the pathogenesis of immune-mediated inflammatory diseases.

Description

While extracellular traps (ETs), formed by neutrophils and other leukocytes, are enriched in citrullinated histones and exert significant pro-inflammatory effects, it remains unclear how distinct macrophage subsets interpret and resolve ET-derived signals.

Here we show that macrophage subsets consistent with pro-inflammatory or inflammation-resolving characteristics, differentially engage with ETs and that antibody binding to ETs reshapes these interactions. Transcriptomic profiling shows that ETs induce a broad profile of pro-inflammatory responses in both macrophage subtypes. While inflammation-resolving macrophages readily phagocytose ETs, pro-inflammatory macrophages exhibit limited uptake.

Read the rest (2 more)

Fc domain-dependent ET phagocytosis by both macrophage subsets is significantly enhanced when ETs are opsonized with an anti-citrullinated histone H2A and H4 monoclonal antibody. Opsonized ETs upregulate expression of genes encoding negative regulators of Mitogen-Activated Protein Kinase (MAPK) signaling and reduce expression of genes encoding pro-inflammatory cytokines and chemokines. Exposure to antibody-opsonized ETs following macrophage activation with LPS and IFN-γ suppresses the T cell-directed features of pro-inflammatory macrophages with reduced surface expression of CD80 and CD86 and decreased secretion of IL-12 and CXCL9.

In inflammation-resolving macrophages antibody-opsonized ETs attenuate MAPK-dependent Toll-like receptor responses and inhibit CXCL9 and CXCL10 production while enhancing IL-10 secretion. Together, these findings describe the pro-inflammatory impact of ET exposure on macrophages and delineate a previously unrecognized regulatory axis by which antibodies targeting ET components reprogram macrophage responses across distinct subsets to suppress their T cell-directed pro-inflammatory activity, highlighting a promising therapeutic strategy for ameliorating ET-driven inflammation.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE33295715 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title